Innova Captab Ltd vs Medicamen Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Innova Captab Ltd is ₹ 941 as of 12 Jun 15:30 . The P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 27.9 on March 2026 . This represents a CAGR of 0.85% over 3 yearsThe P/E Ratio of Medicamen Biotech Ltd changed from 53.8 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 3933 crore on March 2026 . This represents a CAGR of 15.33% over 3 yearsThe Market Cap of Medicamen Biotech Ltd changed from ₹ 652.37 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Innova Captab Ltd for the Mar '26 is ₹ 449.37 crore as compare to the Dec '25 revenue of ₹ 451.95 crore. This represent the decline of -0.57% The revenue of Medicamen Biotech Ltd for the Mar '26 is ₹ 62.38 crore as compare to the Dec '25 revenue of ₹ 47.44 crore. This represent the growth of 31.49% The ebitda of Innova Captab Ltd for the Mar '26 is ₹ 66.66 crore as compare to the Dec '25 ebitda of ₹ 71.05 crore. This represent the decline of -6.18% The ebitda of Medicamen Biotech Ltd for the Mar '26 is ₹ 7.18 crore as compare to the Dec '25 ebitda of ₹ 4.91 crore. This represent the growth of 46.23% The net profit of Innova Captab Ltd changed from ₹ 29.48 crore to ₹ 38.08 crore over 8 quarters. This represents a CAGR of 13.65% The net profit of Medicamen Biotech Ltd changed from ₹ 0.8 crore to ₹ 4.45 crore over 8 quarters. This represents a CAGR of 135.85% The Dividend Payout of Innova Captab Ltd changed from 13.68 % on March 2026 to 13.68 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Medicamen Biotech Ltd changed from 9.78 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Innova Captab Ltd

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

About Medicamen Biotech Ltd

A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
The Company has presence over 35+ countries.
Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

FAQs for the comparison of Innova Captab Ltd and Medicamen Biotech Ltd

Which company has a larger market capitalization, Innova Captab Ltd or Medicamen Biotech Ltd?

Market cap of Innova Captab Ltd is 5,384 Cr while Market cap of Medicamen Biotech Ltd is 311 Cr

What are the key factors driving the stock performance of Innova Captab Ltd and Medicamen Biotech Ltd?

The stock performance of Innova Captab Ltd and Medicamen Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Innova Captab Ltd and Medicamen Biotech Ltd?

As of June 15, 2026, the Innova Captab Ltd stock price is INR ₹941.0. On the other hand, Medicamen Biotech Ltd stock price is INR ₹229.45.

How do dividend payouts of Innova Captab Ltd and Medicamen Biotech Ltd compare?

To compare the dividend payouts of Innova Captab Ltd and Medicamen Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.